logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Karius, Inc.


USPTO Granted Patents = 12


Trademarks = 4

Forward Citations = 46

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Timothy A Blauwkamp (12 out of 13 patents)

silverMedal Igor D Vilfan (12 out of 18 patents)

bronzeMedal Rene Sit (6 out of 7 patents)

4.  Michael Kertesz (5 out of 13 patents)

5.  Michael Rosen (5 out of 9 patents)

6.  Fred C Christians (5 out of 30 patents)

7.  Damek Spacek (3 out of 7 patents)

8.  Shivkumar Venkatasubrahmanyam (3 out of 4 patents)

9.  Sivan Bercovici (3 out of 3 patents)

10.  Lily Blair (3 out of 3 patents)

11.  Peter J Eugster (3 out of 3 patents)

12.  David K Hong (3 out of 3 patents)

13.  Trupti Kawli (3 out of 3 patents)

14.  Michael J Rosen (2 out of 2 patents)

15.  Liza Huijse (1 out of 1 patent)


12 patents:

1. 12753448 - Detection and prediction of infectious disease (2026-10-06),
2. 12601089 - DIRECT-TO-LIBRARY METHODS, SYSTEMS, AND COMPOSITIONS (2026-04-14),
3. 12320036 - Direct-to-library methods, systems, and compositions (2025-06-03),
4. 12291739 - Compositions and methods for enriching populations of nucleic acids (2025-05-06),
5. 11834711 - Sample preparation methods, systems and compositions (2023-12-05),
6. 11692224 - Synthetic nucleic acid spike-ins (2023-07-04),
7. 11674167 - Sample series to differentiate target nucleic acids from contaminant nucleic acids (2023-06-13),
8. 11180800 - Sample preparation methods, systems and compositions (2021-11-23),
9. 11111520 - Compositions and methods for enriching populations of nucleic acids (2021-09-07),
10. 11078532 - Synthetic nucleic acid spike-ins (2021-08-03),
11. 10697008 - Sample preparation methods, systems and compositions (2020-06-30),
12. 9976181 - Synthetic nucleic acid spike-ins (2018-05-22),
Company Overview
Karius, Inc. is a biotechnology company based in Redwood City, California, specializing in advanced diagnostic solutions for infectious diseases. The company leverages its proprietary technology platform to analyze microbial cell-free DNA from blood samples, enabling rapid and accurate identification of pathogens. This innovative approach enhances clinical decision-making and patient outcomes by providing healthcare professionals with critical information to guide treatment strategies. Karius is committed to transforming infectious disease diagnostics through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Karius, Inc. USPTO Patent Assignee Logo
12 Patents

#138 in Redwood City, CA

#6,066 in California

#25,578 in US

#48,209 in the World

Redwood City, CA (US)
Redwood City, CA, United States of America

Karius, Inc.

Forward Citations = 46

19 inventors:

goldMedal Timothy A Blauwkamp (12 out of 13 patents)

silverMedal Igor D Vilfan (12 out of 18 patents)

bronzeMedal Rene Sit (6 out of 7 patents)

4.  Michael Kertesz (5 out of 13 patents)

5.  Michael Rosen (5 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Karius, Inc.. Retrieved from https://idiyas.com/company/karius

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…